Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas

Diseases of the Esophagus

Volumn 21, Issue 1, 2008, Pages 21-29

  Zhang, X F ^a,b   Wang, Y M ^a   Ge, H ^a   Cao, Y Y ^a   Chen, Z F ^a   Wen, D G ^a   Guo, W ^a   Wang, N ^a   Li, Y ^a   Zhang, Jian Hui ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Rizhao Traditional Chinese Hospital   (China)

Author keywords

E cadherin; Esophageal squamous cell carcinoma; Gastric cardiac adenocarcinoma; Polymorphism

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER RISK; CANCER STAGING; CARDIA CARCINOMA; CELL ADHESION; CELL INTERACTION; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRANSCRIPTION REGULATION; TUMOR GROWTH; UNTRANSLATED REGION;

ADENOCARCINOMA; ADULT; AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; CARDIA; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 38049138611     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00724.x     Document Type: Article

References (46)

1. Cai L, Yu S Z, Zhang Z F. Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province. China World J Gastroenterol 2000; 6: 374-6.
2. Matsha T, Erasmus R, Kafuko A B et al. CANSA/MRC Oesophageal Cancer Research Group. Human papillomavirus associated with oesophageal cancer. J Clin Pathol 2002; 55: 587-90.
3. Lavergne D, de Villiers E M. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999; 80: 681-4.
4. Yang C S. Vitamin nutrition and gastroesophageal cancer. J Nutr 2000; 130: 338S-9S.
5. Yokokawa Y, Ohta S, Hou J et al. Ecological study on the risks of esophageal cancer in Ci-Xian, China: The importance of nutritional status and the use of well water. Int J Cancer 1999; 83: 620-4.
6. Launoy G, Milan C H, Faivre J, Pienkowski P, Milan C I, Gignoux M. Alcohol, tobacco and oesophageal cancer: Effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer 1997; 75: 1389-96.
7. Yang G R, Qiu S L. Incidence rate of adenocarcinoma of the gastric cardia, and endoscopic classification of early cardial carcinoma in Henan Province, the People's Republic of China. Endoscopy 1987; 19: 7-10.
8. Victor T, Toit R D, Jordaan A M et al. No evidence for point mutation in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers. Cancer Res 1990; 50: 4911-4.
9. Behrens J, Mareel M M, Van Roy F M et al. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of unomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435-47.
10. Nomura E, Sakuragi N, Fujimoto S. Abnormal E-cadherin expression as a risk factor for deep myometrial invasion and lymph node metastasis in endometrial carcinoma. Nippon Rinsho 1995; 53: 1607-12. (In Japanese.)
11. Naitoh A, Kobayashi S, Iwase H, Kuzushima T. Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential. Nippon Rinsho 1995; 53: 1619-22. (In Japanese.)
12. Chen H C, Chu R Y, Hsu P N et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett 2003; 201: 97-106.
13. Oliveira C, Bordin M C, Grehan N et al. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 2002; 19: 510-7.
14. Si H X, Tsao S W, Lam K Y et al. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett 2001; 173: 71-8.
15. Takeno S, Noguchi T, Fumoto S, Kimura Y, Shibata T, Kawahara K. E-cadherin expression in patients with esophageal squamous cell carcinoma: Promoter hypermethylation, Snail overexpression, and clinicopathologic implications. Am J Clin Pathol 2004; 122: 78-84.
16. Li L C, Chui R M, Sasaki M et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000; 60: 873-6.
17. Shin Y, Kim I J, Kang H C et al. The E-cadherin -347G/GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 2004; 25: 895-9.
18. Becker K F, Reich U, Schott C, Hofler H. Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 1995; 96: 739-40.
19. Keirsebilck A, Van Hoorde L, Gao Y et al. Mechanisms of downregulation of transfected E-cadherin cDNA during formation of invasive tumors in syngeneic mice. Invasion Metastasis 1998; 18: 44-56.
20. Humar B, Graziano F C, Ascinu S et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002; 21: 8192-5.
21. Verhage B A, van Houwelingen K, Ruijter T E, Kiemeney L A, Schalken J A. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 2002; 100: 683-5.
22. Zhang X, Ma X, Zhu Q G, Li L C, Chen Z, Ye Z Q. Association between a C/ A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. J Urol 2003; 170: 1379-82.
23. Tsukino H, Kuroda Y, Nakao H et al. E-cadherin gene polymorphism and risk of urothelial cancer. Cancer Lett 2003; 195: 53-8.
24. Wu M S, Huang S P, Chang Y T et al. Association of the -160 C/A promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002; 94: 1443-8.
25. Kazuya K, Naohide O, Hiroshi Y et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. Int J Oncol 2003; 23: 421-7.
26. Park W S, Cho Y G, Park J Y et al. A single nucleotide polymorphism in the E-cadherin gene promoter -160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003; 18: 501-4.
27. Shin Y, Kim I J, Kang H C et al. A functional polymorphism (-347 G→GA) in the E-cadherin gene is associated with colorectal cancer. Carcinogenesis 2004; 25: 2173-6.
28. Siewert J R, Stein H J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9.
29. Miller S A, Dybes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215.
30. Porter T R, Richards F M, Houlston R S et al. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 2002; 21: 1928-33.
31. Lei H, Sjoberg-Margolin S, Werelius B et al. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 2002; 98: 199-204.
32. Pharoah P D, Oliveira C, Machado J C et al. CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer. Int J Cancer 2002; 101: 196-7.
33. Song C G, Huang C M, Liu X et al. Association of -160 (C→A) polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 557-9.
34. Cao W, Cai L, Rao J Y et al. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 2005; 104: 2400-8.
35. Shen J, Terry M B, Gammon M D et al. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005; 26: 2131-7.
36. Tranah G J, Chan A T, Giovannucci E, Ma J, Fuchs C, Hunter D J. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study. Mol Carcinog 2005; 44: 21-30.
37. Tamer L, Ates N A, Ates C et al. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct 2005; 23: 267-72.
38. Kamataki T, Fujiedaa M, Kiyotani K, Iwano S, Kunitoh H. Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. Biochem Biophys Res Commun 2005; 338: 306-10.
39. Li D, Jiao L, Li Y et al. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 2006; 27: 103-11.
40. Zhang J H, Jin X, Fang S M et al. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis 2004; 25: 2519-24.
41. Frixen U H, Behrens M, Eberle G et al. E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-85.
42. Harigopal M, Berger A J, Camp R L, Rimm D L, Kluger H M. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer. Clin Cancer Res 2005; 11: 4083-9.
43. Hori H, Fujimori T, Fujii S et al. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005; 48: 938-45.
44. Wu Z Y, Zhan W H, Li J H et al. Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis. World J Gastroenterol 2005; 11: 3139-43.
45. Chen X F, Zhang H T, Qi Q Y, Sun M M, Tao L Y. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer 2005; 48: 69-76.
46. Gu H, Shang P, Zhou C. Expression of CD44v6 and E-cadherin in prostate carcinoma and metastasis of prostate carcinoma. Zhonghua Nan Ke Xue 2004; 10: 32-8.